A carregar...
Response and survival in advanced breast cancer after two non-cross-resistant combinations.
A prospective study with two cytotoxic combinations (cyclophosphamide, methotrexate, and fluorouracil (CMF), and adriamycin plus vincristine (AV)) was carried out in 110 patients with advanced breast cancer. There was no significant difference between the treatment groups in the response rate after...
Na minha lista:
Main Authors: | , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
1976
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1639498/ https://ncbi.nlm.nih.gov/pubmed/1260337 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|